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Abstract
Background: Inappropriate prescribing negatively impacts on health and economy of  individual and the society. 
Objectives: To evaluate the prescribing patterns and patients’ opinions on healthcare practices in selected primary health-
care centres (PHC) in Ibadan, South-Western Nigeria.
Methods: A prospective cross-sectional study was carried out among patients and healthcare workers in selected PHCs using 
semi-structured questionnaires. Also, patients’ prescription records were reviewed using the WHO-prescribing indicators. 
Results: About one-half  (210; 52.5%) were very satisfied with convenience of  obtaining prescribed medicines in the PHCs, 
accessibility of  PHC to abode (158;39.5%) and affordable medications (136;34.0%). Patients were dissatisfied with follow-up 
of  care (191; 47.8%), courtesy of  workers (184; 46.3%) and non-availability of  medicines (138;34.5%). Number of  drugs 
per encounter was 5.8±2.3 and % encounter with an antibiotic was >26.8% in each facility. Hematinics accounted for (814; 
35.0%), analgesics (544; 23.4%), antimicrobials (303;13.0%) and antihypertensives (5; 0.2%). 
Conclusion: Primary healthcare attendees were satisfied with medication costs affordability and accessibility of  PHC to 
abode but expressed dissatisfaction with follow-up of  care and courtesy of  workers. Also, inappropriate prescriptions char-
acterized by polypharmacy and overuse of  antibiotics were common underscoring the need for regular training of  PHC 
workers on rational drug use and instituting appropriate measures for improvement. 
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Introduction
Primary healthcare constitutes an integral part of  the 
country’s healthcare system and is the level of  care re-
sponsible for providing basic healthcare services to the 
generality of  the citizens, particularly in the rural areas1. 
In Nigeria, healthcare workers at the primary health-
care (PHC) settings comprise mostly nurses, Commu-
nity Health Extension Workers (CHEW), Community 
Health Officers (CHO), health assistant, and  pharmacy 
technicians whose training and primary responsibility 
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involve prescribing and dispensing of  drugs for minor 
ailments.
The World Health Organization (WHO) defined ra-
tional use of  drug as patients receiving medications 
appropriate to their clinical needs in doses that meet 
their own individual requirements, for an adequate pe-
riod of  time and at the lowest cost to them and their 
community2,3. Thus, appropriate drug utilization is es-
sential in achieving quality of  health and medical care 
for patients. 
Drug use is a complex subject involving the prescriber, 
the patient and the dispenser4. Despite the complexity 
of  drug use, a number of  indicators have been devel-
oped, standardized and evaluated by the WHO5,6. These 
indicators are used to measure drug use in out-patient 
facilities and provide measures of  the optimal use of  
resources in the facilities as well as help in correcting 
deviations from the expected standards and in plan-
ning5,6,7. Drug use indicators are grouped into three 
categories namely prescribing indicators comprising 
average/mean number of  drugs per patient encounter; 
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percentage of  drugs encounter with an injection pre-
scribed; percentage of  drugs encounter with an antibi-
otic prescribed; percentage of  drugs prescribed in ge-
neric name, and percentage of  drugs prescribed from 
the essential drug list (EDL). Others are patient care 
and health facility indicators5,6-8. 
Inappropriate prescribing is known all over the world 
as a major problem of  healthcare delivery especially 
in developing countries9,10,11,12. Irrational prescribing is 
reported to negatively impact on health and economy 
of  individuals and the society13 leading to wastage of  
resources and widespread health hazards14,15. Studies 
within and outside Nigeria have shown varying degrees 
of  inappropriate prescriptions mostly characterized by 
polypharmacy, overuse of  antibiotics and injections in 
public sector health facilities11,16-21. This practice under-
mines the provision of  high-quality health care to the 
people especially at the grassroot where majority of  the 
healthcare workers could be classified as semi-skilled in 
terms of  health literacy. Thus, periodic assessment of  
prescribing patterns and patients’ opinion on the treat-
ment practices of  healthcare workers at the PHC will 
help in identifying specific drug-use problems and pro-
vide policy makers with relevant information that could 
be useful in review and implementation of  rational 
drug prescribing. This study therefore used the WHO 
drug-use indicators to assess the prescribing patterns in 
selected PHC facilities in Ibadan metropolis, while pa-
tients’ opinion on healthcare practices was also sought.
Methods
Study sites
This study was carried out in eight primary healthcare 
centres (PHC) from four randomly selected local gov-
ernment areas (LGAs) among the eleven LGAs with-
in Ibadan metropolis. In each LGA, the PHC at the 
Local Government headquarters and another PHC 
which was purposively selected for high patronage were 
considered. Ibadan is the capital city of  Oyo State in 
South-Western Nigeria with an estimated population of  
2,550,593 according to the 2006 population census22,23. 
Ethical approval for the study was obtained from the 
joint University of  Ibadan/University College Hospi-
tal Institution Review Board (Approval Number: UI/
EC/13/0155; NHREC/05/01/2008a).
Study design
A prospective cross-sectional study was conducted 
among patients and healthcare workers in selected pri-
mary healthcare centres from 4th June to 27th August 
2013, using pre-tested semi-structured questionnaires. 
A review of  patients’ prescription records was also car-
ried out using the World Health Organization (WHO) 
drug-use evaluation criteria5,6.
Inclusion/exclusion criteria and sampling proce-
dure
In the selected PHCs, total sampling of  consented pa-
tients aged 15 years and above who were concurrent-
ly attending the facilities for treatment was done, after 
they had been attended to by the primary care provider. 
Also, all the consented healthcare workers in attendance 
at their respective practice sites were enrolled. Objec-
tives of  the study were explained to patients and health-
care workers individually, after which an informed ver-
bal consent was obtained from individuals to signify 
their intention to participate in the study. Participation 
and consent of  pupil participants between the age of  
≥15 and <18 years was endorsed by the teacher who 
accompanied them to the facility, since individuals with-
in these age groups were generally considered as “mi-
nor”. Clarifications were made for patients who did not 
understand English Language by the principal inves-
tigator. Translation and back-translation of  responses 
were subsequently done to ensure response consistency. 
Pregnant women, as well as non-consented patients and 
healthcare workers were excluded from the study. Par-
ticipation was voluntary and respondents were assured 
of  anonymity and confidentiality of  their responses. 
Subsequently, prescription records in the facilities were 
concurrently reviewed and evaluated.
Sample size determination
The target sample size was calculated based on the esti-
mated population of  5280 patients from the eight PHC 
facilities for a study period of  12 consecutive weeks. 
Preliminary information from the medical record unit 
of  the PHCs indicated that a facility usually has an av-
erage of  55 patients per week (i.e. 55 × 12 weeks × 8 
PHCs = 5280). Also, in each PHC, an average of  13 
healthcare workers of  different cadres were on the em-
ployment pay-roll, giving an estimated population of  
104 HCWs for the eight facilities surveyed. With the 
estimated population and assumptions of  5% margin 
of  error and 95% confidence level, a target sample size 
of  approximately 400 prescriptions, 400 patients and 91 
healthcare workers was computed using a sample size 
calculator (www.surveysystem.com/sscal.html)24, with 
the inclusion of  a 10% attrition rate. 
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Pre-test and validation of  instruments
The questionnaires and drug-use data collection form 
were assessed for clarity and content validity by two 
academic scholars. The questionnaires were pretested 
among five healthcare workers and ten patients in one 
of  the excluded PHCs. Based on validity assessment 
and pre-test, some modifications were made, especially 
questions with dichotomous Yes/No response options 
which were rephrased in ordinal scales to remove ambi-
guity and ensuring clarity of  respondents’ opinion. 
Data collection
Patients’ interview was guided by the questionnaire 
consisting of  two sections. Section A clarified socio-de-
mographic characteristics, while section B obtained 
information on patients’ opinion  on the treatment 
practices of  healthcare workers including mode of  ap-
proach to care and treatment, follow-up system on care 
in the PHC, offer to counsel by the HCW, courtesy of  
healthcare worker to patients, and accessibility of  PHC 
to patient’s residence among others. The self-adminis-
tered questionnaire by the HCW comprised two sec-
tions. Section A obtained socio-demographic data in-
cluding length/year of  practice in respective PHC, and 
section B obtained information on source(s) of  medi-
cines routinely dispensed or recommended for patients, 
and the most frequently dispensed medicines in the 
PHC among other questions. The questionnaire-guided 
patients’ interview took about 20 minutes to complete, 
while the self-administered questionnaire by HCW took 
about 10 minutes. 
Data analysis
Data was sorted, coded and analyzed using Predictive 
Analytics Software version 20. Descriptive statistics 
including frequency, mean ± standard deviation and 
percentage were used to summarize the data. Ranked 
variables were summarized using median value or fif-
tieth percentile while associations among patients of  
different educational background and opinions on the 
healthcare practices were evaluated using Kruskal-Wal-
lis test. The information from the prescription sheets 
were pooled into Microsoft Excel and analysed using 
the WHO core prescribing indicators5,6. Binary cate-
gorization of  drug–use indicator performance for the 
facilities was developed utilizing a cut-off  derived from 
the standard reference values for drug-use indicators in 
public sector health facility16. In this study, value less 
than the upper limit of  standard value was considered 
as “good performance” while value greater than the up-
per limit was considered as “poor performance” with 
respect to the % of  drugs encounter with an antibiotic 
and injection prescribed. Also, for the percent of  drugs 
prescribed by generic name and from the EDL, value 
equal to 100% was considered as “good performance” 
and value less than 100% as “poor performance”. Asso-
ciations/differences between the PHCs regarding drug-
use indicator performance were tested using one-way 
analysis of  variance, Chi-square or Fischer exact test as 
appropriate at p < 0.05 considered significant.
Results
A total of  400 copies of  questionnaires distributed to 
patients within the study period were retrieved and ana-
lysed, giving a response rate of  100%. Two hundred and 
eighty-three (70.8%) patients were aged 21-30 years, 385 
(96.3%) were female and 15 (3.8%) were male. Majority 
(311; 77.6%) were traders and had secondary education 
(262; 65.5%) (see Table 1). 
Patients’opinions on the treatment practices of  HCW 
showed that about one-half  (210; 52.5%) were very sat-
isfied with ease/convenience of  obtaining prescribed 
medicines in the facilities, accessibility of  primary 
healthcare centre (PHC) to abode (158; 39.5%), and af-
fordable medications (136; 34.0%). 
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Table 1: Socio-demographic data of patients (n = 400) 
 
Characteristics Frequency Percent frequency 
Age (years)     
15-20 11 2.8 
21-30 283 70.8 
31-40 56 14.0 
41-50 30 7.5 
51-60 16 4.0 
Above 60 4 1.0 
Sex     
Male 15 3.8 
Female 385 96.3 
Educational 
qualification 
    
No formal education 23 5.8 
Primary 80 20.0 
Secondary 262 65.5 
Tertiary or post 
secondary 
35 8.8 
Marital status     
Single 48 12.0 
Married 351                 87.8                       Divorced 1 0.3 
Widowed 0 0 
Occupation     
Trading/business 311 77.6 
 Public/civil servant 38 9.5 
Artisans 25 6.3 
Student 20 5.0 
Farming 6 1.5 
Duration of attending 
the PHC (in years) 
    
< 1 25 6.3 
1-5 299 74.8 
6-10 64 16.0 
11-15 12 3.0 
 
Patients expressed dissatisfaction with follow-up of  
care (191; 47.8%), courtesy of  workers (184; 46.3%) 
and non-availability of  prescribed medicines (138; 
34.5%) (see Table 2). Patients with secondary and ter-
tiary education were mostly dissatisfied with courtesy 
of  workers as indicated by the lower mean ranks (MR) 
of  192.6 and 145.1 respectively, compared to attendee 
with no formal education having MR of  269.4 and pri-
mary education with MR of  222.0. (p = 0.00). Details 
of  patients’ opinion on healthcare practices in the facil-
ities are shown in Table 2.
Ninety-one copies of  questionnaires distributed among 
healthcare workers were retrieved and analysed, giving a 
response rate of  100%. The cadres of  healthcare work-
ers in the PHC facilities surveyed included communi-
ty health extension workers (59; 64.8%), nurses (20; 
22.0%), community health officers (9; 9.9%), pharmacy 
technicians (2; 2.2%), and physician (1; 1.1%). 
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1. Accessibility of 
the  PHC to 
residence 
55 (13.8) 158(39.5) 124(31.0) 56 (14.0) 7(1.80) 4 0.07 
2.Convenience of 
obtaining prescribed 
medicines in the 
PHC 
44 (11.0) 210(52.5) 146(36.5) 0 0 4 0.02* 
3.Time spent with 
the HCW at every 
encounter 
26 (6.5) 165(41.3) 209(52.3) 0 0 3 0.15 
4. Mode of approach 
to treatment  and 
care by HCW 
23 (5.8) 186(46.5) 189(47.3) 2 (0.5) 0 4 0.29 
5. Affordability of 
costs of prescribed 
medicines per 
encounter 
80 (20.0) 136(34.0) 91 (22.8) 93 (23.3) 0 4 0.02* 
6. Availability of 
prescribed medicines 
in the dispensary 
30 (7.5) 113(28.3) 113(28.3) 138(34.5) 6 (1.5) 3 0.93 
7. Follow up system 
on care by the HCW 
3 (0.8) 39 (9.8) 88 (22.0) 191 (47.8) 79 (19.8) 2 0.004* 
8. Offer to counsel 
by the  HCW 
51 (12.8) 218(54.5) 130(32.5) 1 (0.3) 0 4 0.24 
9. Adequacy of 
information on 
medication use 
28 (7.0) 224(56.0) 143(35.8) 5 (1.3) 0 4 0.80 
10. Courtesy of 
HCW to patients 
while in the PHC 
8(2.0) 55(13.9) 84 (21.2) 184 (46.3) 66(16.5) 2 0.00* 
11. Privacy or 
confidentiality of 
records/information 
by the HCW  
60 (15.0) 189 (47.3) 150 (37.5) 1 (0.3) 0 4 0.02* 
 
Extremely satisfied = 5, Very satisfied = 4, Satisfied = 3, Dissatisfied = 2, Extremely dissatisfied = 1, HCW = Healthcare worker, PHC = 
Primary healthcare centre, Level of statistical significance p < 0.05, *Significant difference with Kruskal-Wallis (K-W) test for the 
distribution of rank variables among respondents with different educational background 
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Year of  practice of  HCW in respective PHC showed 
that four (4.4%) had less than one year, 35 (38.5%) had 
been practiced in the PHC for 1-5 years, 27 (29.7%) for 
6-10 years, 10 (11.0%) for 11-15 years, 11 (12.1%) for 
16-20 years, 2 (2.2%) for 21-25 years, and 2 (2.2%) had 
been in the PHC for 26 years and above. The source 
of  medicines recommended in the facilities included, 
in different combinations, central medical store (67; 
35.4%), drug revolving funds system (25; 13.2%), bulk 
purchase from the wholesaler and re-sell/retail to pa-
tients at a reasonable cost (21;11.1%), while 76 (40.2%) 
reported that they usually recommend for patients to 
buy their medicines elsewhere. 
The WHO drug-use indicators for prescribed medi-
cines in the facilities showed that the mean number of  
drugs prescribed per encounter was 5.8 ± 2.3 (range: 1 
to 14), percentage of  drugs prescribed by generic name 
was <100% for each facility, % of  drugs encounter with 
an antibiotic was >26.8% (standard value: 20–26.8%)16 
for each facility (see Table 3). There were statistically 
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significant differences in the drug-use indicator perfor-
mance of  the facilities with respect to mean number of  
drugs per encounter (F =27.2, p=0.00), % of  drugs en-
counter with an antibiotic (p = 0.034), and % of  drugs 
prescribed by generic name (p = 0.00).  Details of  drug-
use indicator performance for each facility are shown in 
Table 3. 
Table 3: Comparison of drug-use indicator performance for the facilities 
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drugs 
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generic 
(LRV=100) 





IBN IOHC 50 200; 4.0 ± 1.2 24 (48.0) 2 (4.0) 59.5 98.2 
  BHC 50 279; 5.6 ± 1.9 35 (70.0) 22 (44.0) 63.3 99.3 
IBNE IRHC 50 408; 8.2 ± 2.6 38 (76.0) 42 (84.0) 75.4 99.8 
  OAHC 50 250; 5.0 ± 1.8 23 ( 46.0) 46 (92.0) 82.0 99.6 
AKYL MHC 50 328; 6.6 ±2.1 27 (54.0) 39 (78.0) 68.9 99.4 
  OHC 50 362; 7.2 ± 1.6 14 (28.0) 45 (90.0) 67.1 99.5 
EGBD AHC 50 272; 5.4 ± 2.2 32 (64.0) 11 (22.0) 59.8 97.9 
  WHC 50 226; 4.6 ± 1.6 27 (54.0) 3 (6.0) 68.2 99.0 
      F =27.2; p=0.00         
  Facility performance for % 
encounter with an antibiotic 
Facility performance for % of drug prescribed 
in generic 
    Good 


















17 (70.8) 7 (29.2) 44 (88.0) 6(12.0)   
  BHC 29 (82.9) 6 (17.1) 20 (40.0) 30 (60.0)   
IBNE IRHC 34 (89.5) 4 (10.5) 14 (28.0) 36(72.0)   




24 (88.9) 3 (11.1) 26(52.0) 24 (48.0)   
  OHC 13 (92.9) 1 (7.1) 29 (58.0) 21 (42.0)   
EGBD AHC 22 (68.8) 10 (31.3) 24(48.0) 26 (52.0)   
  WHC 16 (59.3) 11 (40.7) 16 (32.0) 34 (68.0)   
                p =0.03              p =0.00   
 
LGA = Local Government Area, IBN = Ibadan North, IBNE= Ibadan North East,  AKYL= Akinyele, EGBD = Egbeda,  Ibadan urban comprised IBN 
&IBNE, Ibadan semi-urban comprised AKYL & EGBD; PHC = Primary Healthcare Centre,  IOHC = Idi-Ogungun Health Centre, BHC = Bashorun 
Health Centre, IRHC = Iwo Road Health Centre, OAHC = Oke-Adu Health Centre, MHC = Moniya Health Centre, OHC = Ojoo Health centre, AHC 
= Alakia Health Centre, WHC = Wakajaye Health Centre,  , EDL = Essential Drug List, LRV = Local  reference value, N = Total number of drugs 
prescribed, n = number of encounter, SD = Standard deviation 
Out of  a total of  2325 medicines prescribed, hemati-
nics/vitamin supplements constituted the highest pro-
portions (814; 35.0%). The details of  prescribed medi-
cines in the facilities are shown in Tables 4, 5 and 6.
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Table 4: Profile of prescribed analgesics, hematinics and antihistamine in the facilities 
 
Drug category/class Specific drug type Number (%) 
Vitamins/hematinics/mineral supplement (n = 814) Vitamin B complex 336 (41.3) 
  Folic acid 176 (21.6) 
  Ascorbic acid (Vitamin C) 171 (21.0) 
  Iron/vitamin B12/folic acid 
combination 
48 (5.9) 
  Multivitamins 36 (4.4) 
  Ferrous sulphate 28 (3.4) 
  Calcium 14 (1.7) 
  Zinc sulphate 5 (0.6) 
Analgesics/antipyretics/anti-inflammatory (n =544) Paracetamol 440 (80.9) 
  Diclofenac 90 (16.5) 
  Ibuprofen 6 (1.1) 
                                                                                          
                                                               
Acetylsalicylic acid                4 (0.7)              
 
  Methylsalicylate 2 (0.4) 
  Piroxicam 1 (0.2) 
  Trypsin/Chymotrypsin 1 (0.2) 
Antihistamine/antiallergic (n = 99) Chlorpheniramine maleate 65 ( 65.6) 
  Promethazine 20 (20.2) 
  Meclozine 4 (4.0) 
  Hydrocortisone 4 (4.0) 
  Prednisolone 3 (3.0) 
  Cetrizine 2 (2.0) 
  Diphenylhydramine 1 (1.0) 
  Table 5: Profile of prescribed antimalarial and antibiotics in the facilities 
 
Drug category/class Specific drug type Number (%) 
Antimicrobials (n = 303) Amoxicillin 77 (25.4) 
  Metronidazole 61(20.1) 
  Gentamicin 32  (10.6) 
  Erythromycin 26 (8.6) 
  Ciprofloxacin 20 ( 6.6) 
  Ampicillin/cloxacillin 18 ( 5.9) 
  Co-trimoxazole 13 (4.3) 
  Ampicillin 9 (3.0) 
  Cefuroxime 7 (2.3) 
  Cephalexin 7 (2.3) 
  Ofloxacin 7 (2.3) 
  Procaine penicillin 7 (2.3) 
  Crystalline penicillin 5 (1.7) 
  Amoxicillin/clavulanic acid 4 (1.3) 
  Phythalysulfathiazole 3 (1.0) 
  Doxycycline 2 (0.7) 
  Sulfadimidine 2 (0.7) 
  Tetracycline 2 (0.7) 
  Cefixime 1 (0.3) 
Antimalarial (n = 299) Artemeter/lumefantrine 224 (74.9) 
 Artesunate/amodiaquine 56 (18.7) 
  Artesunate monotherapy 12 (4.0) 
  Quinine 6 (2.0) 
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Discussion
In this study, a substantial number of  PHC attendees 
were women, mostly with secondary education and in 
their younger ages of  21-30 years. This seems consist-
ent with the report in literature that women in Nigeria 
constitute 60-79% of  the rural workforce25, which is a 
statutory location where the primary healthcare centres 
are generally situated. Also, evidence from around the 
world including Nigeria has shown that women lag be-
hind in education and employment, and tend to have 
lower levels of  literacy compared to men25,26. In addi-
tion, studies across different settings have found that, 
on average, women reported more symptoms than 
men even when their illness status was similar27, and 
that men tend to seek healthcare at later stages and at 
a higher level of  healthcare as compared to women28. 
Therefore, high patronage of  the PHCs by younger 
women may further emphasize the need to strengthen 
and consolidate the primary healthcare services, since 
studies have shown that women in low income coun-
tries including Nigeria tend to have reproductive health 
challenges which places a high financial and medical 
Table 6: Summary of other prescribed medicines in the facilities 
 
Drug category/class Specific drug type Number (%) 
Antacids (n =35) Magnesium trisilicate 23 (65.7) 
  Simethicone/aluminiumhydroxide/magnesium 
combination 
8 (22.9) 
  Aluminium hydroxide and magnesium 
hydroxide combination 
3 (8.6) 
  Aluminium hydroxide 1 (2.9) 
Antihelmintics (n = 31) Pyrantel permoate 21 (67.7) 
  Mebendazole 7 (22.6) 
  Levamizole 3 (9.7) 
Anxiolytics (n =24) Diazepam 21 (87.5) 
  Bromazepam 3 (12.5) 
Antihypertensive (n = 5) Nifedipine 1 (20.0) 
  Atenolol  1 (20.0) 
  Methyldopa 1 (20.0) 
  Amiloride/hydrochlorthiazide 1 (20.0) 
  Amlodipine 1 (20.0) 
Antifungals (n = 4) Clotrimazole 2 (50.0) 
  Nystatin 1 (25.0) 
  Ketoconazole 1 (25.0) 
*Others    167 (7.2) 
 
*Include Oral Rehydration Salt (ORS) (n =79), Metoclopramide (n = 43), Hyoscine-N-butyl bromide (n = 19), Glucose (n = 8), 
Calamine lotion (n =6), Tetanus toxoid (n =4), Mist potassium citrate (n =2), Bisacodyl (n = 1), Dequalinium hydrochloride (n =1), 
Glycerin of borax (n =1), Iodine (n =1), Salbutamol (n =1). 
burden on women than men25,29-32. This is in addition to 
the fact that women’s empowerment which is the third 
of  the eight millennium development goals underpin 
the achievement of  all the other Millennium Develop-
ment Goals25,29,30. 
It is noteworthy that a high proportion of  the patients 
expressed satisfaction with ease or convenience of  ob-
taining the prescribed medicines in the PHC and acces-
sibility of  healthcare facility to their abode. This finding 
possibly implies that the local government authority 
saddled with the primary responsibility of  construct-
ing primary healthcare centre at their respective domain 
need to be commended. However, it was observed that 
a sizeable number of  patients were dissatisfied with 
non-availability of  prescribed medicines in the PHC 
facilities, thereby prompting the need to recommend 
purchase of  medicine elsewhere. This practice usually 
creates avenue for treatment of  non-adherence among 
patients generally. The availability and convenience of  
obtaining prescribed medicines in a facility are crit-
ical components that may largely determine the pub-
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lic health facility’s performance in terms of  medicine 
accessibility by patients. Literature reports that about 
one-third of  the world population lacks access to essen-
tial medicines leading to morbidity and mortality par-
ticularly for infectious and chronic illness4,7. Equipping 
the primary healthcare centres with adequate essential 
medicines and qualified healthcare personnel should 
therefore be given priority attention. The 1978 Alma 
Ata conference identified the availability, quality and ra-
tional use of  essential medicines as one of  the cardinal 
components of  primary healthcare33,34. 
In this study, a substantial number of  patients were sat-
isfied with affordable medications but expressed dissat-
isfaction with follow-up system on care and courtesy 
of  HCW while in the PHC. Patients’ expression of  
dissatisfaction with the follow-up system on care is a 
call for concern, though, the non-follow-up of  care by 
PHC workers may be expected since PHCs are statuto-
rily established to cater for minor ailments which may 
not necessarily require active follow-up on care. Any 
situation of  complicated or chronic medical condition 
at the PHC level are to be promptly and properly re-
ferred to the nearest secondary or tertiary healthcare 
settings.  However, these findings further underscore 
the need for periodic evaluation of  patients’ opinion 
on the healthcare practices at the public health facilities, 
so as to ensure identification of  problem areas to focus 
on for future intervention. Patients’ expression of  dis-
satisfaction with courtesy of  PHC workers is an issue 
of  great concern that needs to be addressed by all PHC 
stakeholders. Courtesy and use of  empathy during pa-
tient-provider interaction should be advocated and en-
couraged, so as to ensure truthful and mutual therapeu-
tic relationship between the provider and patients35-37.
Majority reported satisfaction with the mode of  ap-
proach to treatment and care by the HCW, while sub-
stantial proportions were barely satisfied with the time 
spent during treatment in the PHC.  It is however im-
portant to note that the quality and content of  informa-
tion provided during counselling are key determinants 
of  patients’ satisfaction with the counselling, while 
prompt and active attention to patient’s need and com-
plaints may be a key element in gauging the effective-
ness of  service delivery of  a facility. Primary healthcare 
workers may need to take cognizance of  these findings 
and consider appropriate measures for improvement.  
In this study, the healthcare workers involved in pre-
scribing and dispensing of  medicines were largely 
community health workers and nurses. Babalola et al21 
also reported these cadres of  healthcare workers as the 
predominant healthcare professionals in the primary 
healthcare system.  The dearth of  skilled and qualified 
healthcare personnel including physician and phar-
macist to serve in rural and remote areas where most 
of  the PHCs were located might have accounted for 
undue involvement of  different cadres of  semi-skilled 
healthcare workers whose training only entails pre-
scribing of  medicines for minor ailments. Inadequate 
knowledge of  the primary healthcare workers on the 
rational chronological order of  the dispensing process 
had earlier been reported in similar settings38. Howev-
er, considering the importance, patronage and proxim-
ity of  primary healthcare to the generality of  citizens, 
it has become essential to allocate more resources to 
such settings with an attractive remuneration package 
so as to continuously encourage and motivate qualified 
and skilled healthcare workers especially physicians and 
pharmacists to practice at the PHC facilities, in order to 
assure the quality of  primary healthcare delivery. 
It is noteworthy to mention that polypharmacy prac-
tice, inappropriate use of  antibiotics and injections 
were common in the facilities surveyed. This is consist-
ent with studies in public sector health facilities within 
and outside Nigeria11,21,39-42. Inappropriate prescribing is 
reported to negatively impact on health and econom-
ics of  individuals and the society leading to wastage of  
scarce resources and widespread health hazards13,14,15.
In this study, prescribing by generic name could be de-
scribed as moderate compared to the standard value of  
100%. The percentage of  generic prescription is high-
er than values reported in other studies conducted in 
developing countries11,16,18,43-45. However, much higher 
values of  generic prescription (75.0% to 99.8%) have 
been reported from Bangladesh44 and Cambodia46. Pre-
scribing in generics without compromising therapeutic 
efficacy may be better appreciated by the patient on ac-
count of  cost reduction compared to the branded drug 
products40. In addition to the lower economic cost to 
patients, generic prescribing will eliminate or reduce 
the incidence of  therapeutic duplication or errors47. 
Furthermore, it was observed that substantial propor-
tions of  prescribed medicines were from the EDL with 
a higher value than what has been reported in most 
of  the previous studies21,44,45,48-50. Prescribing from the 
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National EDL provides a framework for rational pre-
scribing with lower cost than prescribing newer drugs 
or medicines not in the EDL51. 
Hematinics/vitamin supplements were the most com-
monly prescribed medicines in the facilities. Other 
studies have alsoreported analgesics and hematinics 
as the frequently prescibed medicines in the facilities 
studied11,21,39-42.  The increased prescription of  arteme-
ter-lumefantrine for malaria showed a good compliance 
to the WHO recommendations and the National Stand-
ard Treatment Guidelines (STG) for malaria treatment52. 
However, presumptive use of  artemisinin-based drugs 
for empirical treatment of  acute uncomplicated malaria 
may need to be discouraged as this totally deviates from 
the WHO and STG for malaria52. In addition, the per-
centage of  antibiotics prescribed in this study is higher 
than reported in most other studies21,40. Hogerzeil et al42 
reported figures of  47.5% to 100% of  encounters with 
antibiotic prescriptions, while a lower rate (17.5%) of  
antibiotics prescription was reported in Nepal43. Studies 
have reported that antibiotics are one of  the groups of  
drugs involved in adverse drug reactions (ADRs) and 
are greatly misused and overprescribed in Nigeria53,54. 
Inappropriate use of  antibiotics should be discouraged 
as this may potentially lead to antimicrobial resistance 
and increase the necessity to use more expensive antibi-
otics to treat common and life-threatening infections40. 
Regular and ongoing training on rational use of  drugs is 
therefore advocated for all categories of  healthcare pro-
viders involved in prescribing and dispensing of  drugs 
at the PHC so as to continuously ensure optimal care 
for the people. In this study, it was noted that prescrip-
tion of  medications for chronic condition was generally 
low, possibly implying that HCW at the PHC level were 
within the limit of  their statutory job description with 
regard to the treatment and management of  chronic 
diseases.
Despite the useful information from this study, it was 
limited by the fact that patient care and health facility 
indicators which are part of  the comprehensive WHO 
drug-use evaluation criteria5,6,8 were not explored. How-
ever, this information might have allowed the oppor-
tunity of  assessing the average consultation and dis-
pensing time as a measure to gauge the effectiveness 
of  service delivery in the PHC, as well as ascertaining 
patients’ knowledge of  the correct usage of  prescribed 
regimen. Nonetheless, future studies may need to con-
sider inclusion of  more PHC facilities, as well as criti-
cally assess other drug-use indicators, so as to ensure far 
reaching conclusions.
Conclusion
Patrons of  primary healthcare facilities in Ibadan me-
tropolis were mostly satisfied with convenience of  ob-
taining prescribed medicines in the PHC, accessibility 
of  facility to places of  abode and affordable medica-
tions but were dissatisfied with the follow-up system on 
care, courtesy of  HCW during treatment and non-avail-
ability of  prescribed medicines in the PHC’s dispensa-
ry suggesting needs for PHC workers to redouble their 
efforts in order to continuously ensure improved care. 
Also, moderate generic prescription as well as inap-
propriate prescribing characterized by polypharmacy, 
overuse of  antibiotics and injections were observed un-
derscoring the need for regular and ongoing training 
on rational use of  drugs for the PHC workers, while 
qualified healthcare personnel, especially physicians and 
pharmacists need to be motivated and encouraged to 
practice at the PHC level, so as to assure quality health-
care to the people.
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